go back

Ranibizumab (Susvimo) Sustained-Release Implant

Pennsylvania rates for HCPCS C9093

Injection, ranibizumab, via sustained release intravitreal implant (Susvimo), 0.1 mg

Rates data updated July 2026.

Facilitymedian $81 · 10th–90th $81$1050%50%90th$81Professionalmedian $81 · 10th–90th $81$810%50%$81$100.0

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$81.28
Median
$81.28
Typical High
$104.71
Aetna
Setting
Professional
Modifier
Global
Typical Low
$81.28
Median
$81.28
Typical High
$81.28
Martin's Point
Setting
Facility
Modifier
Global
Typical Low
$81.28
Median
$81.28
Typical High
$104.71
Martin's Point
Setting
Professional
Modifier
Global
Typical Low
$81.28
Median
$81.28
Typical High
$81.28